For a patient with a pre‑meal capillary blood glucose of 272 mg/dL who has already eaten dinner, which rapid‑acting insulin should be administered now?

Post‑Meal Rapid‑Acting Insulin for Immediate Hyperglycemia

Administer 2 units of rapid‑acting insulin (lispro, aspart, or glulisine) immediately as a correction dose, because a capillary glucose of 272 mg/dL after eating dinner warrants prompt intervention to bring the glucose back toward target range. 1

---

Rationale for Immediate Correction

• A pre‑meal glucose of 272 mg/dL (15.1 mmol/L) is well above the target range of 80–130 mg/dL fasting and <180 mg/dL postprandial, indicating inadequate glycemic control that requires correction. 1
• The simplified correction‑insulin protocol recommends 2 units of rapid‑acting insulin for glucose >250 mg/dL and 4 units for glucose >350 mg/dL; at 272 mg/dL, the appropriate dose is 2 units. 1
• Rapid‑acting insulin analogues (lispro, aspart, glulisine) have an onset of action within 0.25–0.5 hours, peak at 1–3 hours, and duration of 3–5 hours, making them ideal for correcting acute hyperglycemia. 2, 3

---

Timing and Administration

• Administer the correction dose immediately after discovering the elevated glucose, even though the patient has already eaten, because rapid‑acting insulin will still blunt the post‑meal glucose excursion and bring the current level down. 1, 4
• Ideally, rapid‑acting insulin should be given 0–15 minutes before meals for optimal postprandial control, but when a meal has already been consumed, giving it immediately afterward is the next best option. 1, 5
• Do not delay correction when glucose exceeds 250 mg/dL, as prolonged hyperglycemia increases the risk of acute and chronic complications. 1

---

Why Not Wait or Use a Different Insulin?

• Basal insulin (e.g., glargine, detemir, degludec) is designed to suppress hepatic glucose production between meals and overnight; it has a slow onset (1–2 hours) and is not appropriate for correcting acute hyperglycemia. 1, 5
• Regular (short‑acting) insulin has a slower onset (30–60 minutes) and longer duration (6–8 hours) than rapid‑acting analogues, making it less ideal for immediate correction and increasing the risk of delayed hypoglycemia. 6, 2
• Sliding‑scale insulin as monotherapy (correction doses without scheduled basal and prandial insulin) is condemned by major diabetes guidelines because it reacts to hyperglycemia rather than preventing it, leading to dangerous glucose fluctuations. 1, 7

---

Monitoring After Correction

• Recheck capillary glucose 1–2 hours after the correction dose to ensure the glucose is falling toward target (<180 mg/dL postprandial). 1
• If glucose remains >300 mg/dL after 2 hours, give an additional correction dose and investigate underlying causes (e.g., inadequate basal insulin, missed prandial dose, illness, steroid use). 1
• Observe for symptoms of hypoglycemia (shakiness, sweating, confusion, rapid heartbeat) as the glucose begins to fall, especially if the patient has not eaten recently or has taken other glucose‑lowering medications. 8

---

Addressing the Underlying Regimen Failure

• A glucose of 272 mg/dL after dinner signals that the patient's current insulin regimen is inadequate and requires systematic restructuring, not just reactive correction doses. 1, 7
• Basal insulin should be titrated to achieve fasting glucose of 80–130 mg/dL; if fasting glucose is ≥180 mg/dL, increase basal insulin by 4 units every 3 days. 1, 7
• Prandial insulin should be given before each meal to cover carbohydrate intake and prevent postprandial spikes; start with 4 units per meal (or 10% of the basal dose) and titrate by 1–2 units every 3 days based on 2‑hour postprandial glucose. 1, 7
• Correction doses must supplement—not replace—scheduled basal and prandial insulin; relying solely on corrections perpetuates inadequate control. 1, 7

---

Safety Considerations

• Treat glucose <70 mg/dL immediately with 15 g of fast‑acting carbohydrate (e.g., 4 glucose tablets, 4 oz juice), recheck in 15 minutes, and repeat if needed. 1, 8
• If hypoglycemia occurs without an obvious cause, reduce the implicated insulin dose by 10–20% before the next administration. 1
• Never administer rapid‑acting insulin at bedtime as a sole correction dose, as this markedly raises the risk of nocturnal hypoglycemia. 1, 7

---

Common Pitfalls to Avoid

• Do not delay correction when glucose exceeds 250 mg/dL; prolonged hyperglycemia increases complication risk. 1
• Do not rely solely on correction doses without addressing the underlying regimen failure; scheduled basal and prandial insulin must be optimized. 1, 7
• Do not use basal insulin (e.g., Lantus, Toujeo) to correct acute hyperglycemia; its slow onset makes it ineffective for immediate correction. 1, 5
• Do not withhold correction insulin because the patient has already eaten; rapid‑acting insulin will still lower the current glucose level and blunt the postprandial rise. 1, 4

---

Expected Outcome

• With a 2‑unit correction dose of rapid‑acting insulin, glucose should fall by approximately 30–50 mg/dL within 1–2 hours, bringing the level closer to the target range of <180 mg/dL postprandial. 1
• If the patient's regimen is optimized with adequate basal and prandial insulin, ≈68% of patients achieve mean glucose <140 mg/dL, compared with ≈38% when dosing is inadequate. 1, 7